Efficacy and safety of octreotide for the treatment of congenital hyperinsulinism: a prospective, open-label clinical trial and an observational study in Japan using a nationwide registry. (Q38681983)
Jump to navigation
Jump to search
scientific article published on 11 July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of octreotide for the treatment of congenital hyperinsulinism: a prospective, open-label clinical trial and an observational study in Japan using a nationwide registry. |
scientific article published on 11 July 2017 |
Statements
Efficacy and safety of octreotide for the treatment of congenital hyperinsulinism: a prospective, open-label clinical trial and an observational study in Japan using a nationwide registry (English)
Yuki Hosokawa
Rie Kawakita
Susumu Yokoya
Keiichi Ozono
Osamu Arisaka
Yukihiro Hasegawa
Satoshi Kusuda
Michiya Masue
Hironori Nishibori
Toshimi Sairenchi
Tohru Yorifuji